These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37395952)

  • 1. Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis.
    Lubrano E; Scriffignano S; Perrotta FM
    Rheumatol Ther; 2023 Oct; 10(5):1119-1125. PubMed ID: 37395952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demographic and Clinical Factors Associated with Patient-Reported Remission in Psoriatic Arthritis.
    Gondo G; Mosca M; Hong J; Maverakis E; Merola JF; Armstrong AW; Bhutani T; Bell SJ; Liao W
    Dermatol Ther (Heidelb); 2022 Aug; 12(8):1885-1895. PubMed ID: 35864377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease Control with Upadacitinib in Patients with Psoriatic Arthritis: A Post Hoc Analysis of the Randomized, Placebo-Controlled SELECT-PsA 1 and 2 Phase 3 Trials.
    Mease P; Kavanaugh A; Gladman D; FitzGerald O; Soriano ER; Nash P; Feng D; Lertratanakul A; Douglas K; Lippe R; Gossec L
    Rheumatol Ther; 2022 Aug; 9(4):1181-1191. PubMed ID: 35606663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Multidomain Disease Presentations on Patients With Psoriatic Arthritis in the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
    Ogdie A; Hur P; Liu M; Rebello S; McLean RR; Dube B; Glynn M; Mease PJ
    J Rheumatol; 2021 May; 48(5):698-706. PubMed ID: 33004532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difficult to treat psoriatic arthritis - how should we manage?
    Kumthekar A; Ashrafi M; Deodhar A
    Clin Rheumatol; 2023 Sep; 42(9):2251-2265. PubMed ID: 37097525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating to target in psoriatic arthritis: assessing real-world outcomes and optimising therapeutic strategy for adults with psoriatic arthritis-study protocol for the MONITOR-PsA study, a trials within cohorts study design.
    Rombach I; Tillett W; Jadon D; Tucker L; Watson M; Francis A; Sinomati Y; Eldridge L; Dritsaki M; Dutton SJ; Al-Mossawi H; Gullick N; Thompson B; Coates LC
    Trials; 2021 Mar; 22(1):185. PubMed ID: 33663566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Calprotectin as a Promising Inflammatory Biomarker in Psoriatic Arthritis: a 1-Year Longitudinal Study.
    Li B; Li G; Song Z; Zhang Z
    Rheumatol Ther; 2023 Feb; 10(1):149-160. PubMed ID: 36271188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secukinumab Efficacy on Psoriatic Arthritis GRAPPA-OMERACT Core Domains in Patients with or Without Prior Tumor Necrosis Factor Inhibitor Use: Pooled Analysis of Four Phase 3 Studies.
    Orbai AM; Husni ME; Gladman DD; Leung YY; Siebert S; Tillett W; Vis M; Chambenoit O; Meng X; Mease PJ
    Rheumatol Ther; 2021 Sep; 8(3):1223-1240. PubMed ID: 34218429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriatic arthritis: is it time to treat-to-target or target to treat?
    Lubrano E; Perrotta FM
    Clin Rheumatol; 2017 Dec; 36(12):2633-2635. PubMed ID: 29067586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of low disease activity and remission in psoriatic arthritis.
    Lubrano E; Perrotta FM; Kavanaugh A
    Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S51-4. PubMed ID: 26470835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical remission in rheumatoid arthritis and psoriatic arthritis.
    Lubrano E; Mesina F; Caporali R
    Clin Exp Rheumatol; 2018; 36(5):900-910. PubMed ID: 29600949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring treatment effect on psoriatic arthritis-related domains: insights from the SPIRIT-H2H study at weeks 24 and 52.
    Behrens F; Leage SL; Sapin C; Baou CE; De La Torre I; Meszaros G; Schett G; Combe B; van den Bosch F; Gossec L
    Clin Rheumatol; 2021 Dec; 40(12):4943-4954. PubMed ID: 34515902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Need for Improvement in Current Treatment of Psoriatic Arthritis: Study of an Outpatient Clinic Population.
    Michelsen B; Diamantopoulos AP; Høiberg HK; Soldal DM; Kavanaugh A; Haugeberg G
    J Rheumatol; 2017 Apr; 44(4):431-436. PubMed ID: 28148701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual symptoms and disease burden among patients with psoriatic arthritis: is a new disease activity index required?
    Kilic G; Kilic E; Nas K; Kamanlı A; Tekeoglu İ
    Rheumatol Int; 2019 Jan; 39(1):73-81. PubMed ID: 30426235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current concepts and new developments in the treatment of psoriatic arthritis.
    Pipitone N; Kingsley GH; Manzo A; Scott DL; Pitzalis C
    Rheumatology (Oxford); 2003 Oct; 42(10):1138-48. PubMed ID: 12810935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. More than a random association between chronic obstructive pulmonary disease and psoriatic arthritis: shared pathogenic features and implications for treatment.
    Quartuccio L; Sebastiani M; Spinelli FR; Di Marco F; Peluso R; D'Angelo S; Cauli A; Rossini M; Atzeni F
    Expert Rev Clin Immunol; 2022 Sep; 18(9):983-990. PubMed ID: 35881045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Considerations for the definition of remission criteria in psoriatic arthritis.
    Mease PJ; Coates LC
    Semin Arthritis Rheum; 2018 Jun; 47(6):786-796. PubMed ID: 29566966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey.
    Lebwohl M; Langley RG; Paul C; Puíg L; Reich K; van de Kerkhof P; Wu HL; Richter S; Jardon S; Gisondi P
    Dermatol Ther (Heidelb); 2022 Jan; 12(1):61-78. PubMed ID: 34704231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What Should Be the Primary Target of "Treat to Target" in Psoriatic Arthritis?
    Coates LC; Lubrano E; Perrotta FM; Emery P; Conaghan PG; Helliwell PS
    J Rheumatol; 2019 Jan; 46(1):38-42. PubMed ID: 30219765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Insights in Physical Therapy and Rehabilitation in Psoriatic Arthritis: A Review.
    Perrotta FM; Scriffignano S; Benfaremo D; Ronga M; Luchetti MM; Lubrano E
    Rheumatol Ther; 2021 Jun; 8(2):639-649. PubMed ID: 33710586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.